相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Heterogeneity of Recent Phase 3 Complicated Urinary Tract Infection Clinical Trials
Simon Portsmouth et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
Third-generation cephalosporin resistance in clinical isolates of Enterobacterales collected between 2016-2018 from USA and Europe: genotypic analysis of β-lactamases and comparative in vitro activity of cefepime/enmetazobactam
Adam Belley et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2021)
Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection
Mariana Castanheira et al.
JAC-ANTIMICROBIAL RESISTANCE (2021)
Beyond Piperacillin-Tazobactam: Cefepime and AAI101 as a Potent β-Lactam - β-Lactamase Inhibitor Combination
Krisztina M. Papp-Wallace et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Fosfomycin for Injection (ZTI-01) Versus Piperacillin-tazobactam for the Treatment of Complicated Urinary Tract Infection Including Acute Pyelonephritis: ZEUS, A Phase 2/3 Randomized Trial
Keith S. Kaye et al.
CLINICAL INFECTIOUS DISEASES (2019)
Variations in the Occurrence of Resistance Phenotypes and Carbapenemase Genes Among Enterobacteriaceae Isolates in 20 Years of the SENTRY Antimicrobial Surveillance Program
Mariana Castanheira et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
In Vitro Activity of Cefepime-Enmetazobactam against Gram-Negative Isolates Collected from US and European Hospitals during 2014-2015
Ian Morrissey et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
1477. A Randomized Phase 2 Study of Cefepime Combined with the Novel Extended Spectrum β-Lactamase Inhibitor Enmetazobactam in Hospitalized Adults with Complicated Urinary Tract Infections (cUTI) Including Acute Pyelonephritis (AP)
Yehuda Carmeli et al.
Open Forum Infectious Diseases (2019)
Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection The TANGO I Randomized Clinical Trial
Keith S. Kaye et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Carbapenem-Sparing Therapy for Extended-Spectrum β-Lactamase-Producing E coli and Klebsiella pneumoniae Bloodstream Infection The Search Continues
Mary K. Hayden et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Prevalence of Antimicrobial Use in US Acute Care Hospitals, May-September 2011
Shelley S. Magill et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Correlations of Antibiotic Use and Carbapenem Resistance in Enterobacteriaceae
Milena McLaughlin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Cefepime: a reappraisal in an era of increasing antimicrobial resistance
Andrea Endimiani et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2008)
分享论文
